REVENUE (Tables)

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2022		2021		2022		2021
Screening
Medicare Parts B & C	$	140,366	$	116,088	$	389,373	$	329,034
Commercial	188,923		151,245		531,789		419,268
Other	31,470		13,045		100,013		36,341
Total Screening	360,759		280,378		1,021,175		784,643
Precision Oncology
Medicare Parts B & C	$	47,038	$	51,607	$	152,224	$	144,753
Commercial	42,660		42,844		134,658		136,800
International	31,533		27,229		89,536		80,133
Other	30,212		23,732		81,640		50,942
Total Precision Oncology	151,443		145,412		458,058		412,628
COVID-19 Testing	$	10,871	$	30,589	$	52,051	$	96,004
Total	$	523,073	$	456,379	$	1,531,284	$	1,293,275